Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | C134-HSV-1 |
| Synonyms | |
| Therapy Description |
C134-HSV-1 is an oncolytic HSV/HCMV chimeric virus that potentially induces tumor cell death and anti-tumor immune response (PMID: 29216507). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| C134-HSV-1 | C134|C-134|C 134|HSV-1 C134 | C134-HSV-1 is an oncolytic HSV/HCMV chimeric virus that potentially induces tumor cell death and anti-tumor immune response (PMID: 29216507). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03657576 | Phase I | C134-HSV-1 | Trial of C134 in Patients With Recurrent GBM (C134-HSV-1) | Active, not recruiting | USA | 0 |
| NCT06614855 | Phase I | C134-HSV-1 | A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma | Active, not recruiting | USA | 0 |
| NCT06193174 | Phase I | C134-HSV-1 | Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1) | Enrolling by invitation | USA | 0 |